Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ranibizumab MeSH Descriptor Data 2026


MeSH Heading
Ranibizumab
Tree Number(s)
D12.776.124.486.485.114.224.060.868
D12.776.124.790.651.114.224.060.868
D12.776.377.715.548.114.224.200.868
Unique ID
D000069579
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069579
Scope Note
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
Entry Term(s)
Lucentis
RhuFab V2
Pharm Action
Angiogenesis Inhibitors
Registry Numbers
ZL1R02VT79
0
Related Numbers
347396-82-1
See Also
Vascular Endothelial Growth Factor A
Public MeSH Note
2016; RANIBIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011
History Note
2016 (2005)
Date Introduced
2016/01/01
Last Updated
2017/04/10
Ranibizumab Preferred
Lucentis Narrower
page delivered in 0.16s